Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001510281-25-000226

10% owner sold 9,144 shares at $11.78 ($107,716)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Saba Capital Management, L.P. 10% owner 2025-04-17 Sale −9,144 $11.78 $107,716 3,068,072 I
Open-market sales · 9,144 sh · avg $11.78 · $107,716
Loading xslF345X05/primary_doc.xml…